BLT
Click for more information
0.00% 2.6¢ benitec biopharma limited

2gb interview, page-10

  1. Hoyland
    4,015 Posts.
    lightbulb Created with Sketch. 127
    clock Created with Sketch.
    27/05/13
    15:57
    Post #: 11813784
    Maybe management are just being deliberately misleading in today's announcement when they say HCV and HBV partnerships will be sought after Pl/ll? Or have they just forgotten to change the slide?

    P26

    ! Internal!product!pipeline!

    " Selected"for"technology"?t,"target"valida-on"
    status,"medical"need,"market"size,"etc."

    Strategy is to develop with partners

    Pre-clinical(AMD,"Tubulin,"Pain,"OPMD)"
    After phaseI/II(HCV,HBV)
    Typically will retain co-promote op-on
    BLT Price at posting: 40.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Training with professional athletes: How to invest like the best
right-arrow Created with Sketch.
ABY Adore Beauty appoints former David Jones exec as new CEO
right-arrow Created with Sketch.
MIN MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned
right-arrow Created with Sketch.
DEG De Grey sees more production at Hemi with latest drilling at Crow, Aquila
right-arrow Created with Sketch.
NVA Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter
right-arrow Created with Sketch.
NEWS Super PITch gold sponsor RSM Australia: Can Diggers & Dealers 2024 be key to reinvigorating IPO activity?
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.